Convatec AGM Trading Update for the Four Months Ended 30 April 2023

Convatec Group Plc (Convatec) AGM trading update for the four months ended 30 April 2023.


Convatec AGM Trading Update for the Four Months Ended 30 April 2023 - cover page
Brand
ConvaTec
Document type
Other
Language
English
Pages
2
File format
PDF
File size
95 KB
Published
17 November, 2023
Updated
17 November, 2023
MD5 checksum
61E63BA645262FB28C56B2AD241CE246

About this manual

Convatec Group Plc, a global medical products and technologies company, published an AGM trading update for the four months ended 30 April 2023. Organic revenue increased by 3.1%, while reported revenue decreased by 1.7% after the exit of hospital care activities and related industrial sales in 2022.

The company raised its 2023 organic revenue growth guidance to between 5.0% and 6.5% and expects its constant currency operating profit margin to reach at least 19.7%. The update also covers strategic progress, including an anti-infective technology acquisition, plant network optimization, and new product innovation.

What's inside

  • Good start to 2023 – revenue guidance increased
  • Strategic progress over the last four months
  • Revenue guidance increased
  • Footnotes
  • Contacts
  • About Convatec
  • Forward Looking Statements

Frequently asked questions

What was Convatec's organic revenue growth for the four months ended 30 April 2023?

Organic revenue increased by 3.1% on an organic basis for the four months ended 30 April 2023.

What is Convatec's updated organic revenue growth guidance for 2023?

Convatec now expects organic revenue growth for 2023 to be between 5.0% and 6.5%.

What operating profit margin does Convatec expect on a constant currency basis?

The company expects to increase its operating profit margin on a constant currency basis to at least 19.7%.

Download PDF (95 KB)